Back to results
US 7,022,718 B2Granted
Pyridine and pyrimidine derivatives
AssigneeHoffmann-La Roche Inc.
InventorsMarkus Boehringer, Bernd Michael Loeffler, Jens-Uwe Peters, Matthias Steger, Peter Weiss
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds of formula (I) wherein R1, R2, R3, R4 and X are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.
Claims16
A compound of formula (I)
- wherein
- X is C—R5;
- R1 and R2 are independently hydrogen or lower alkyl;
- R3 is heterocyclyl;
- heterocyclyl mono-, di-, or tri-substituted, independently, by lower alkyl, lower alkoxy, perfluoro-lower alkyl, amino or halogen;
- aryl;
- or aryl mono-, di-, or tri-substituted, independently, by halogen, lower alkyl, lower alkoxy, amino or perfluoro-lower alkyl;
- R4 is lower alkyl;
- lower alkoxy;
- lower alkylthio;
- heterocyclyl;
- heterocyclyl mono-, di-, or tri-substituted, independently, by lower alkyl, lower alkoxy, perfluoro-lower alkyl, amino or halogen;
- aryl;
- aryl mono-, di-, or tri-substituted, independently, by lower alkyl, lower alkoxy, halogen, amino, or perfluoro-lower alkyl;
- aryloxy lower alkyl or cycloalkyl;
- R5 is hydrogen or lower alkyl;
- or a pharmaceutically acceptable salt thereof.
14 more elements
Dependencies are inferred from the claim text.